In triple-negative breast cancer, PTPRZ1 is overexpressed, as assessed by immunohistochemistry in 325 cases of breast cancer, and it may be an independent risk indicator for recurrence and metastasis [97]. This evidence concerns the gene PTPRZ1 and breast carcinoma.